News for 'biotechnology'

Is this Indian Covid vaccine better than Pfizer's?

Is this Indian Covid vaccine better than Pfizer's?

Rediff.com12 Dec 2020

India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.

Oxford vaccine doing 'everything expected': Study

Oxford vaccine doing 'everything expected': Study

Rediff.com22 Oct 2020

A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.

Reliance Life to shift to IPCL

Reliance Life to shift to IPCL

Rediff.com26 May 2003

'Red tape stifling India's biotech sector'

'Red tape stifling India's biotech sector'

Rediff.com15 Apr 2003

Bureaucratic delays are stifling growth in the sector. India should be far more aggressive in launching 'look alike' biological molecules in a fast track manner.

Controversial biotech regulator bill introduced in LS

Controversial biotech regulator bill introduced in LS

Rediff.com22 Apr 2013

A bill to establish a statutory independent regulator for biotech sector covering research, transport, import, manufacture and use of organisms and products of modern biotechnology was introduced in the Lok Sabha on Monday.

Country needs biotech policy: Kalam

Country needs biotech policy: Kalam

Rediff.com22 Mar 2003

President A P J Abdul Kalam on Saturday said the country needed a national biotech policy for tapping the full potential of the science and utilising it for economic development.

Biotech sector major thrust area: Govt

Biotech sector major thrust area: Govt

Rediff.com21 Mar 2003

Government on Friday said it was eyeing the biotechnology sector as a major thrust area and would improve regulatory mechanisms for rational promotion of genetically-modified organisms.

'It is as if secular means not to speak about religion'

'It is as if secular means not to speak about religion'

Rediff.com27 Jun 2013

Dr B Ashok, an IAS officer from Kerala, explains why he wrote a controversial article supporting the invite to Narendra Modi by a mutt in the state.

Leaders, activists come together against GM crops

Leaders, activists come together against GM crops

Rediff.com26 Jun 2013

Political leaders cutting across party lines have joined hands with the civil society to launch a nationwide campaign against GM crops and the Biotechnology Regulatory Authority of India Bill.

Biotech bug bites Ranbaxy

Biotech bug bites Ranbaxy

Rediff.com6 Feb 2003

Biotech sector set for a boom

Biotech sector set for a boom

Rediff.com24 Sep 2003

India's biotech sector is expected to grow 25-30 per cent during the current fiscal over Rs 1,830 crore revenue generated during 2002-03, according to a joint survey by the Association of Biotechnology Led Enterprises and Biospectrum.

Eminent scientist P M Bhargava passes away

Eminent scientist P M Bhargava passes away

Rediff.com1 Aug 2017

Bhargava is a pioneer in the field of biotechnology in the country.

Health ministry ready to roll out COVID-19 vaccine in around a week

Health ministry ready to roll out COVID-19 vaccine in around a week

Rediff.com5 Jan 2021

Addressing a press briefing, Union Health Secretary Rajesh Bhushan said healthcare workers and frontline workers need not register themselves as their database has been populated on to the Co-WIN vaccine delivery management system in a bulk manner.

Pharma firms in biotech thrust

Pharma firms in biotech thrust

Rediff.com14 Aug 2003

The inspiring story of a BPO in Rajasthan

The inspiring story of a BPO in Rajasthan

Rediff.com18 Jul 2013

Shrot Katewa from Jhunjhunu district of Rajasthan started 'Source for Change'- a rural BPO to empower the women of his village through professional training activities leading to employment. This is his story.

Subsidy for jobs creation, IT relief for homes: FM

Subsidy for jobs creation, IT relief for homes: FM

Rediff.com12 Nov 2020

Finance Minister Nirmala Sitharaman on Thursday announced a new job creation scheme by giving subsidy to those establishments that make new hires. The subsidy would be to cover for retirement fund contributions by employees as well as employers for two years, she said. Employees contribution (12 per cent of wages) and employer's contribution (12 per cent of wages) totalling 24 per cent of wages would be given to establishments for two years, she said. Under the Aatmanirbhar Bharat Rozgar Yojana, every Employees' Provident Fund Organisation (EPFO)-registered establishment taking new employees would get this subsidy.

Scientists in Kashmir successfully clone Pashmina goat

Scientists in Kashmir successfully clone Pashmina goat

Rediff.com13 Mar 2012

Scientists at the Kashmir Agriculture University have produced the world's first cloned Pashmina goat.

Trump administration revokes new student visa order

Trump administration revokes new student visa order

Rediff.com15 Jul 2020

The announcement comes as a big relief to international students, including those from India.

7 jobs in DEMAND

7 jobs in DEMAND

Rediff.com27 Jan 2021

There will be a huge market for healthcare professionals, data and security experts and digital marketers, says Navneet Singh, founder, Avsar HR Services.

Apply for the Stanford-India Biodesign Fellowship

Apply for the Stanford-India Biodesign Fellowship

Rediff.com27 Apr 2012

Apply for the Stanford-India Biodesign Fellowship in Biomedical Technology Innovation or the S K Patil Loan Scholarships to study abroad. Read on for details

Top US doctor cautiously optimistic over COVID vaccine

Top US doctor cautiously optimistic over COVID vaccine

Rediff.com9 Jul 2020

There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.

3 COVID vaccines under active consideration: Health ministry

3 COVID vaccines under active consideration: Health ministry

Rediff.com8 Dec 2020

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.

In PHOTOS: The world's first cloned pashmina goat

In PHOTOS: The world's first cloned pashmina goat

Rediff.com15 Mar 2012

Scientists at the Kashmir Agriculture University have produced the world's first cloned pashmina goat.

BRICS: Why India must stand up for itself

BRICS: Why India must stand up for itself

Rediff.com30 Mar 2012

We have to be much more rigorous and analytical in assessing the importance of the BRICS, says Parag Khanna.

Covid Vaccine IP: How Big Pharma lobbied against India

Covid Vaccine IP: How Big Pharma lobbied against India

Rediff.com9 Jun 2021

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual property.

Biocon's accounting process comes under scanner

Biocon's accounting process comes under scanner

Rediff.com22 May 2012

Biotech company denies all charges.

After brawl with ABVP activists, JNU student goes missing

After brawl with ABVP activists, JNU student goes missing

Rediff.com18 Oct 2016

Najeeb Ahmad, pursuing MSc in Biotechnology and resident of room 106 of Mahi/Mandavi hostel, has been missing since yesterday allegedly after an altercation with a few students on Saturday night, they added.

Phase II trial finds Chinese COVID-19 vaccine is safe

Phase II trial finds Chinese COVID-19 vaccine is safe

Rediff.com21 Jul 2020

Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.

18 hottest technology innovators from India

18 hottest technology innovators from India

Rediff.com11 Mar 2011

Their exceptional technical contributions hold great promise to shape our future.

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

Rediff.com24 Nov 2020

Almost each of these companies has a different technology to show for the effectiveness against microbes.

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Rediff.com10 Oct 2020

Eminent Indian-origin academician Srikant Datar has been named as Dean of Harvard Business School, succeeding Nitin Nohria and becoming the second consecutive dean hailing from India to lead the prestigious 112-year-old institution. Datar, an alumnus of University of Bombay and Indian Institute of Management, Ahmedabad, is the Arthur Lowes Dickinson Professor of Business Administration and the senior associate dean for University Affairs at Harvard Business School (HBS). He will assume charge as the school's next dean on January 1, president Larry Bacow said.

PM Modi, Belgian PM Michel jointly launch Asia's biggest telescope

PM Modi, Belgian PM Michel jointly launch Asia's biggest telescope

Rediff.com30 Mar 2016

Prime Minister Narendra Modi and his Belgian counterpart Charles Michel remotely launched Asia's biggest telescope, the ARIES, built with Belgian assistance.

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.

Biocon Q3 net up 9% at Rs 93 crore

Biocon Q3 net up 9% at Rs 93 crore

Rediff.com25 Jan 2013

The Bengaluru-headquartered firm had posted a net profit of Rs 84.85 crore (Rs 848.5 million) during the same period of previous fiscal.

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

Beware! 9 regulations that put students in a soup

Beware! 9 regulations that put students in a soup

Rediff.com10 Oct 2011

From MBBS to biotechnology, across academic and professional programmes, the regulators have consistently been betraying the trust students place in them. Read on to find out how.

CBSE puts class XII sample papers on its site

CBSE puts class XII sample papers on its site

Rediff.com15 Dec 2011

The CBSE has mounted 32 sample papers of Class XII and of 28 other examinations on its website and students can download them free.

Pfizer, Bicon scrap insulin deal

Pfizer, Bicon scrap insulin deal

Rediff.com13 Mar 2012

US-based drugmaker Pfizer and Indian biotechnology major Bicon today said they have agreed to end their alliance to sell insulin and insulin analog products made by the Indian company.

Covid vaccine possible by 2021 first quarter: Vardhan

Covid vaccine possible by 2021 first quarter: Vardhan

Rediff.com13 Sep 2020

Vardhan stated the government is taking full precautions in human trials of vaccines and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr V K Paul, member-health, NITI Aayog, is drawing up a detailed strategy on how to immunize the majority of the population.